Adrian N Hobden's Net Worth

$13.9 Million

Estimate Recalculated Nov 1, 2024 08:35AM EST

Who is Adrian N Hobden

Adrian N Hobden has an estimated net worth of $13.9 Million. This is based on reported shares across multiple companies, which include Myriad Pharmaceuticals, Inc., and MYRIAD GENETICS INC.

SEC CIK

Adrian N Hobden's CIK is 0001191076

Past Insider Trading and Trends

2008 was Adrian N Hobden's most active year for acquiring shares with 11 total transactions. Adrian N Hobden's most active month to acquire stocks was the month of August. 2008 was Adrian N Hobden's most active year for disposing of shares, totalling 13 transactions. Adrian N Hobden's most active month to dispose stocks was the month of August. 2009 saw Adrian N Hobden paying a total of $710,304.15 for 328,900 shares, this is the most they've acquired in one year. In 2009 Adrian N Hobden cashed out on 182,900 shares for a total of $3,366,934.40, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Myriad Pharmaceuticals, Inc.

President and CEO
Updated Sep 28, 2010
Form 4
99.98%
166.67K
Sep 28, 2010
333.37K
Grant
Sep 24
Form 4
$1.38
$38.65K
Apr 19, 2010
162.79K
Options
Apr 16
Form 4
17.42%
20.00K
$4.41
$88.20K
Mar 19, 2010
134.78K
Purchase
Mar 18
Form 4
$1.23
$5.49K
Mar 04, 2010
114.78K
Options
Mar 02
Form 4
80.00K
Feb 22, 2010
80.00K
Grant
Feb 18
Form 4/A
80.00K
Sep 14, 2009
80.00K
Grant
Sep 10
Form 4
80.00K
Sep 14, 2009
80.00K
Grant
Sep 10
Form 4
85.45%
50.00K
Jul 06, 2009
108.52K
Grant
Jul 01
Form 3
Jun 11, 2009
Showing 9 results

MYRIAD GENETICS INC

Pres. Myriad Pharmaceuticals
Updated Jun 08, 2009
Form 4
$10.76
$399.95K
Jun 08, 2009
243.80K
Options
Jun 08
Form 4
-16.97%
-40.00K
$18.20
-$1.26M
May 29, 2009
195.73K
Sale
May 27
Form 4
$5.64
$99.99K
May 11, 2009
195.73K
Options
May 08
Form 4
-18.05%
-24.00K
$44.19
-$1.89M
Feb 05, 2009
108.99K
Sale
Feb 05
Form 4
-13.07%
-20.00K
$32.69
-$1.12M
Dec 11, 2008
132.99K
Sale
Dec 11
Form 4
$5.13
$107.97K
Sep 30, 2008
88.99K
Options
Sep 29
Form 4
-14.42%
-15.00K
$36.84
-$976.89K
Sep 25, 2008
88.99K
Sale
Sep 23 - Sep 25
Form 4
-0.94%
-992.00
$35.57
-$60.39K
Sep 23, 2008
103.99K
Sale
Sep 19
Form 4
-0.47%
-500.00
$35.81
$20.57K
Sep 19, 2008
104.98K
Sale
Sep 17 - Sep 18
Form 4
45.00K
Sep 12, 2008
45.00K
Grant
Sep 10
Form 4
-30.38%
-27.46K
$35.08
-$1.65M
Aug 27, 2008
62.92K
Sale
Aug 25
Form 4
$5.13
$51.25K
Mar 12, 2008
105.18K
Options
Mar 10
Form 4
55.00K
Feb 29, 2008
55.00K
Grant
Feb 28
Form 4
$5.13
$25.63K
Dec 04, 2007
104.80K
Options
Nov 30
Form 4
45.00K
Sep 28, 2007
45.00K
Grant
Sep 26
Form 4
-21.12%
-20.00K
$38.79
-$1.90M
Sep 27, 2007
74.70K
Sale
ScheduledSep 25
Form 4
-9.59%
-10.00K
$22.57
-$348.75K
May 23, 2007
94.25K
Sale
ScheduledMay 23
Form 4
34.00K
Feb 22, 2007
34.00K
Grant
Feb 21
Form 4
-4.58%
-5.00K
$18.57
-$134.37K
Jan 03, 2007
104.25K
Sale
ScheduledJan 03
Form 4
32.00K
Sep 07, 2006
32.00K
Grant
Sep 06
Form 4
-4.42%
-5.00K
$15.57
-$104.42K
Apr 27, 2006
108.11K
Sale
ScheduledApr 27
Form 4
32.00K
Feb 16, 2006
32.00K
Grant
Feb 16
Form 4
40.00K
Sep 16, 2005
40.00K
Grant
Sep 14
Form 4
45.00K
Feb 17, 2005
45.00K
Grant
Feb 17
Form 4
-1.78%
-2.02K
$15.07
-$40.23K
Jan 14, 2005
111.64K
Sale
ScheduledJan 13
Form 4
40.00K
Sep 09, 2004
40.00K
Grant
Sep 08
Form 4
$5.13
$15.38K
Aug 06, 2004
101.05K
Options
Aug 05
Form 4
30.00K
Feb 20, 2004
30.00K
Grant
Feb 19
Form 4
35.00K
Sep 10, 2003
35.00K
Grant
Sep 09
Form 4
Jul 10, 2003
Showing 30 results